ArticleBMC cancer2024

Real-world dosing of regorafenib and outcomes among patients with metastatic colorectal cancer: a retrospective analysis using US claims data.

Tanios Bekaii-Saab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.